Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Montivilliers

14 clinical trials in Montivilliers, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Montivilliers at a glance
14
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

14 trials in Montivilliers

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ambrisentan
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Intergroupe Francophone Du Myelome
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Les Hopitaux Universitaires De Strasbourg
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Les Hopitaux Universitaires De Strasbourg
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Fondation A De Rothschild
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Systemic scleroderma

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Centre Hospitalier Universitaire Rouen

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Montivilliers

What the registry says about research in the country

01 Multiple Myeloma Research

Innovative studies focusing on elranatamab-lenalidomide combinations for newly diagnosed multiple myeloma patients, exploring alternatives to traditional chemotherapy and transplant approaches.

  • Consolidation therapy optimization
  • Maintenance treatment evaluation
  • MRD negativity assessment

Additional research examines Isatuximab treatment protocols for elderly patients ineligible for transplants.

02 Rheumatoid Arthritis Studies

Comprehensive trials evaluating different treatment approaches for rheumatoid arthritis, including maintenance therapy optimization and comparative effectiveness studies.

  • Rituximab dosing strategies
  • Targeted therapy evaluation
  • Combined treatment protocols

Research comparing the efficacy of triple therapy versus targeted treatments in patients with insufficient response to conventional medications.

03 Therapeutic Innovations

Advanced clinical investigations focusing on developing personalized treatment approaches for both hematologic and autoimmune conditions.

  • Novel drug combinations
  • Age-specific protocols
  • Treatment optimization strategies

Studies aim to improve treatment outcomes while considering patient-specific factors and quality of life measures.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.